ArticleMelanoma research2026
Reversal of rare paraneoplastic syndromes in melanoma: fever and cutaneous melanosis.
Article in Melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraneoplastic syndromes (PNS), manifestations of systemic effects of a tumor, are rare in patients with melanoma. We describe two cases of patients who presented with rare PNS, fever, and cutaneous melanosis, that resolved after treatment of melanoma. The first patient, a 64-year-old woman, presented with high fever. After diagnostic evaluation, infectious causes were excluded and the patient was diagnosed with metastatic melanoma. The fever was attributed as a PNS. After surgical removal of a large necrotic intramuscular metastasis in her leg, her fever dissolved completely, allowing continuation of immunotherapy. The second patient, a 76-year-old man, presented with a grayish skin pigmentation and dark urine and referred to the gastroenterologist. He was diagnosed with metastatic melanoma and his symptoms were recognized as cutaneous melanosis. After initiation of immunotherapy, the pigmentation gradually faded. This case series show two distinct and rare paraneoplastic phenomena in melanoma. Early recognition and tailored management of PNS is crucial, as these syndromes may obscure underlying malignancy or influence patient's overall condition. In our cases, PNS resolved after tumor-directed treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.